Covered recipient · General Payments record
HALEY M MCCULLOUGH
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$747.91
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $304.57 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $199.72 | 14 |
| GlaxoSmithKline, LLC. | $49.88 | 2 |
| Exact Sciences Corporation | $20.89 | 1 |
| Novo Nordisk AS | $18.60 | 1 |
| Lilly USA, LLC | $15.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.50 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879959 | CMS |
| ABBVIE INC. | $10.32 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879961 | CMS |
| ABBVIE INC. | $7.24 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879963 | CMS |
| ABBVIE INC. | $6.37 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879965 | CMS |
| ABBVIE INC. | $20.12 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879967 | CMS |
| ABBVIE INC. | $5.50 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879969 | CMS |
| ABBVIE INC. | $6.19 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879971 | CMS |
| ABBVIE INC. | $2.63 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879973 | CMS |
| ABBVIE INC. | $19.85 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879975 | CMS |
| ABBVIE INC. | $24.98 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879977 | CMS |
| ABBVIE INC. | $7.44 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879979 | CMS |
| ABBVIE INC. | $23.29 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879981 | CMS |
| ABBVIE INC. | $46.14 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879983 | CMS |
| ABBVIE INC. | $4.15 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106879985 | CMS |
| Exact Sciences Corporation | $20.89 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114515510 | CMS |
| GlaxoSmithKline, LLC. | $23.84 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116732920 | CMS |
| GlaxoSmithKline, LLC. | $26.04 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116382614 | CMS |
| Lilly USA, LLC | $15.48 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135677257 | CMS |
| Novo Nordisk Inc | $18.60 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100532281 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.